Andrew Martin

Amgen Inc (AMGN)

Equibles does not estimate personal net worth.

Get an email with a short summary when Amgen Inc publishes a filing, an earnings call transcript or a press release.

Get AMGN alerts

About Andrew Martin

Andrew Martin has spoken on 1 investor event across 1 company, most recently for Amgen Inc on September 6, 2026. Amgen Inc is classified in the Drug Manufacturers - General industry within the Healthcare sector. Other leadership on record at Amgen Inc includes Robert Bradway (CEO), David W. Meline (CFO), Thomas Dittrich (CFO) and 7 others.

Andrew Martin on recent calls

“It's a very, very important flagship operation in manufacturing for us.”

Other, Goldman Sachs 47th Annual Global Healthcare Conference · September 6, 2026

Affiliation history

Amgen Inc (AMGN)
Transcript header (unverified)

Current

Company network

AMGN

Current role

Drug Manufacturers - General · Healthcare

1 appearance Latest appearance 2026-09-06

View calls and events

Leadership on record at Amgen Inc

Robert Bradway CEO
David W. Meline CFO
Thomas Dittrich CFO
David M. Reese, M.D. CTO
Sean Bruich CTO
Jonathan P. Graham General Counsel
Linda H. Louie Chief Accounting Officer
Matthew C. Busch Chief Accounting Officer
Amy E. Miles Board Member
Michael V. Drake Board Member

Recent activity

Conference Goldman Sachs 47th Annual Global Healthcare Conference Amgen Inc (AMGN)
2026-09-06